Stemtech Corporation
STEK · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 22.1% | -19.6% | -33.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 80.1% | 79.1% | 83% | 79.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $2 | $1 |
| SG&A Expenses | $1 | $1 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $2 | $1 |
| Operating Income | -$0 | -$0 | -$1 | $0 |
| % Margin | -25.1% | -43.1% | -138.8% | 2.5% |
| Other Income/Exp. Net | -$1 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$0 | -$1 | -$0 |
| Tax Expense | -$1 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -0.4% | -42% | -167.7% | -30.2% |
| EPS | -0.01 | -0.002 | -0.01 | -0.003 |
| % Growth | -376.2% | 79% | -244.8% | – |
| EPS Diluted | -0.01 | -0.002 | -0.01 | -0.003 |
| Weighted Avg Shares Out | 150 | 142 | 119 | 119 |
| Weighted Avg Shares Out Dil | 150 | 142 | 119 | 119 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$1 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | $0 |
| % Margin | -25.1% | -25% | -135% | 11.9% |